ROSIELLO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 2.311
EU - Europa 2.207
AS - Asia 1.694
SA - Sud America 430
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 49
Totale 6.831
Nazione #
US - Stati Uniti d'America 2.160
RU - Federazione Russa 1.248
SG - Singapore 623
CN - Cina 481
BR - Brasile 322
IT - Italia 312
SE - Svezia 224
HK - Hong Kong 205
VN - Vietnam 176
DE - Germania 95
FR - Francia 89
CA - Canada 73
GB - Regno Unito 69
BD - Bangladesh 55
IN - India 53
FI - Finlandia 48
AR - Argentina 41
MX - Messico 28
NL - Olanda 28
PL - Polonia 25
EC - Ecuador 20
ID - Indonesia 20
ZA - Sudafrica 19
IQ - Iraq 15
JP - Giappone 14
CO - Colombia 13
PE - Perù 12
AT - Austria 9
CR - Costa Rica 9
ES - Italia 9
LT - Lituania 9
MY - Malesia 9
VE - Venezuela 9
GT - Guatemala 8
IE - Irlanda 8
UA - Ucraina 8
HN - Honduras 7
JM - Giamaica 7
MA - Marocco 7
TR - Turchia 7
UZ - Uzbekistan 7
TN - Tunisia 6
BE - Belgio 5
BO - Bolivia 5
EG - Egitto 5
PK - Pakistan 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
NP - Nepal 4
SV - El Salvador 4
AZ - Azerbaigian 3
BG - Bulgaria 3
KE - Kenya 3
MD - Moldavia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
JO - Giordania 2
NI - Nicaragua 2
PH - Filippine 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LC - Santa Lucia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
Totale 6.691
Città #
Singapore 329
Ashburn 323
Moscow 212
Hong Kong 201
San Jose 198
Dallas 191
Council Bluffs 118
New York 103
Shanghai 103
Milan 78
Los Angeles 72
Hefei 68
Ho Chi Minh City 67
Beijing 61
Lauterbourg 56
Boardman 51
Lawrence 50
Princeton 50
Phoenix 47
Santa Clara 38
Munich 35
Hanoi 32
Helsinki 26
São Paulo 26
North Bergen 25
Denver 23
Montreal 23
Rome 22
Atlanta 20
Orem 20
Warsaw 20
Turku 19
Brooklyn 18
Frankfurt am Main 17
Manchester 17
Miano 17
Chicago 16
Houston 16
Johannesburg 15
Chennai 13
Haiphong 13
Mexico City 13
Rio de Janeiro 13
Bologna 12
Guangzhou 12
San Francisco 12
Naples 11
Poplar 11
Tokyo 11
Toronto 11
Lima 10
Mumbai 10
Columbus 9
Amsterdam 8
Bar Harbor 8
Nuremberg 8
Quito 8
Shenzhen 8
Washington 8
Belo Horizonte 7
Brasília 7
Da Nang 7
Falkenstein 7
Guatemala City 7
Hyderabad 7
The Dalles 7
Barnet 6
Biên Hòa 6
Dhaka 6
Dronten 6
Dublin 6
Guayaquil 6
Las Vegas 6
London 6
Manaus 6
Seattle 6
Stockholm 6
Tashkent 6
Turin 6
Bari 5
Boston 5
Catania 5
Kingston 5
Memphis 5
Miami 5
Pune 5
Querétaro 5
San José 5
Vienna 5
Borås 4
Brussels 4
Buffalo 4
Duque de Caxias 4
Hangzhou 4
Hải Dương 4
Ipatinga 4
Jacksonville 4
Jiaxing 4
Kansas City 4
Paris 4
Totale 3.253
Nome #
Bladder cancer incidence rates and trends in young adults aged 20-39 years 270
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 194
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 187
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 152
Pulmonary lesion after surgery for renal cancer: progression or new primary? 151
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 142
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 138
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 138
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 135
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 135
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 132
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 130
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 128
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 128
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 128
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 125
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 122
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 122
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 120
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 119
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 117
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 112
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 109
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 108
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 105
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 103
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 103
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 99
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 97
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 93
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer 91
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium 90
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 89
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 89
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 88
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer 88
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study 86
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 85
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 85
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 83
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 79
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 76
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 72
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 70
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 70
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA 68
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 68
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 68
Erratum: Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010 (European urology oncology PII: S2588-9311(23)00237-7) 67
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 67
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 66
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 65
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 63
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder 59
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 58
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 56
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 55
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma 55
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 54
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy 54
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 54
Re: Stamatio Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920–9 53
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 53
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines 53
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 52
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 51
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 49
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 49
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 39
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 30
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study 28
Re: Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 27
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery 26
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer Patients 24
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathway 22
Acute kidney injury (AKI) and end stage kidney disease (ESKD) in CKD patients undergoing partial or radical nephrectomy for renal cancer: are we ready to unravel the uncertainty and create new hope? 17
Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center 15
Adjuvant pembrolizumab plus belzutifan versus placebo in clear cell renal cell carcinoma: a reconstructed survival data analysis of the KEYNOTE-564 and the LITESPARK-022 trials 15
Re: Antonio Franco, Francesco Ditonno, Celeste Manfredi, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2026;89:318–331 15
Impact of timing between neoadjuvant therapy and radical cystectomy on survival in muscle-invasive bladder cancer 15
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility 13
Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence 11
Comment to: "Oncologic outcomes of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type" 8
Predicting the Risk of Progression in Patients with Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting 6
Totale 6.831
Categoria #
all - tutte 36.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 13 2 1 0 0 1 0 1 11
2022/2023358 131 84 35 5 6 42 6 29 15 0 1 4
2023/2024334 20 20 29 21 20 52 8 61 7 9 17 70
2024/20251.034 111 42 54 45 31 79 125 102 134 135 77 99
2025/20263.828 255 244 264 460 323 100 266 320 1.084 212 149 151
2026/20271.199 151 318 250 480 0 0 0 0 0 0 0 0
Totale 6.831